Envío mundial con seguimiento | Aprox. 9–14 días hábiles

Tu carrito

Tu carrito está vacío

Comenzar a explorar

Envío gratuito en pedidos superiores a €500.

Subtotal€0
Proceder al pago
CognitivoClínico temprano

Pinealon

Investigación publicada y base de evidencia

Pinealon is the synthetic tripeptide Glu-Asp-Arg (EDR), one of the short peptide bioregulators developed by Khavinson and colleagues at the St Petersburg Institute of Bioregulation and Gerontology. The proposed mechanism is epigenetic: the peptide is described as entering the nucleus and binding specific DNA sequences and histone proteins, thereby modulating expression of genes involved in apoptosis, antioxidant defence and neuroplasticity. The available evidence is almost entirely in vitro or rodent work from this single research group, supplemented by molecular-modelling studies; controlled human data are limited to small Russian occupational and geriatric studies of peptide combinations rather than EDR alone.

En resumen
  • Pinealon es el tripéptido sintético Glu-Asp-Arg (EDR).
  • Estudios celulares y animales reportan que modula genes de apoptosis y defensa.
  • No existe ensayo humano controlado de Pinealon solo; los estudios humanos son pequeños y rusos.

21 estudios · 3 desde 2023 · más reciente 2024

Estudios citados
21
Publicados en 2023+
3
Artículo más reciente
2024
Última revisión
oct 2026

Temas recurrentes en la literatura

  • ultrashort peptide bioregulator
  • Glu-Asp-Arg / EDR
  • epigenetic gene regulation
  • peptide-DNA interaction
  • oxidative stress and ROS
  • dendritic spine preservation
  • geroprotection
  • Alzheimer's disease models

Identificadores del compuesto

CAS
175175-23-2
PubChem
10273502

Identidad química

Qué es Pinealon, químicamente.

Fórmula molecular
C15H26N6O8
Peso molecular
418.40 g/mol
Número CAS
175175-23-2
PubChem CID
10273502

Estas cifras provienen del registro PubChem para este compuesto y describen la base libre. El péptido liofilizado normalmente se suministra como sal de acetato o trifluoroacetato y contiene agua residual, por lo que la masa de polvo en un vial no es la misma cantidad que sugeriría el peso molecular anterior. La pureza cromatográfica en un certificado de análisis tampoco resuelve esa diferencia — cómo leer un certificado de análisis explica por qué.

La evidencia

21 estudios publicados.

Ordenados por solidez del diseño del estudio, luego por antigüedad. Cada entrada enlaza a su registro fuente para que el hallazgo pueda verificarse contra el artículo en lugar de tomarse bajo nuestra palabra.

  1. 01Clínico humano2016· Russian (English abstract)

    [Comparative analysis of different methods of geroprotective].

    Myakotnykh VS, et al. · Adv Gerontol · comparative monitoring study, n=110 people of different age groups, comparing dry carbon dioxide baths, hyperbaric oxygen therapy, therapeutic massage and the oligopeptide preparations Vezugen and Pinealon; allocation method not stated in the abstract

    The largest improvement in biological-age indicators was seen with combined use of the two oligopeptide preparations, Vezugen and Pinealon. Therapeutic massage and the oligopeptide preparations were judged the safest methods by biochemical and immunological parameters and clinical condition, while dry carbon dioxide baths and hyperbaric oxygenation had limitations and contraindications.

  2. 02Clínico humano2015· Russian (English abstract)

    [EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION].

    Meshchaninov VN, et al. · Adv Gerontol · clinical study, n=32 adults aged 41-83 with polymorbidity and organic brain syndrome in remission, pinealon and vesugen

    Both peptides improved biological-age indicators and central nervous system activity, with vesugen showing the larger effect; chemiluminescence indicated prooxidant activity, CD34+ haematopoietic cells in blood decreased, and chromatin condensation was unchanged.

    Hallazgo de seguridad reportado. Prooxidant activity and a fall in circulating CD34+ haematopoietic cells (interpreted by the authors as inhibited haemopoiesis) were observed.

  3. 03Clínico humano2012· Russian (English abstract)

    [The peptide correction of neurotic disorders among professional truck-drivers]

    Bashkireva AS, Artamonova VG · Advances in Gerontology (Uspekhi Gerontologii) · occupational clinical trial, 150 male lorry drivers (mean age 43.3) and 150 male metal craftsmen as controls; peptide bioregulators including pinealon and vezugen

    Application of bioregulating peptides was reported to improve psychoemotional indices and reduce occupational risk of borderline mental disorders, with the best effect from combined pinealon and vezugen. Pinealon was not tested alone and the design was not placebo-controlled.

  4. 04Clínico humano2012· Russian (English abstract)

    [Analysis of some parameters of biological age and adaptation possibilities of workers of locomotive brigades].

    Nazimko VA, et al. · Adv Gerontol · uncontrolled observational study, workers of locomotive crews taking oral Pinealon capsules for two weeks; n not stated in the abstract

    Pinealon use was followed by improvement in biological-age parameters and in indicators of the effectiveness of adaptive reactions. No control group is described in the abstract.

  5. 05Animal in vivo2021

    Neuroprotective Effects of Tripeptides-Epigenetic Regulators in Mouse Model of Alzheimer's Disease

    Khavinson V, Ilina A, Kraskovskaya N, Linkova N, Kolchina N, Mironova E, Erofeev A, Petukhov M · Pharmaceuticals · 5xFAD transgenic mice, daily intraperitoneal KED at 400 microg/kg from 2 to 4 months of age, plus molecular docking of peptides to dsDNA

    KED and EDR prevented dendritic spine loss in 5xFAD-M mice. Docking identified EDR binding sites in promoter regions of CASP3, NES, GAP43, APOE, SOD2, PPARA, PPARG and GDX1. A correction to this article was published in 2025 (PMID 39861198).

  6. 06Animal in vivo2015· Russian (English abstract)

    [Pinealon and Cortexin influence on behavior and neurochemical processes in 18-month aged rats within hypoxia and hypothermia]

    Mendzheritsky AM, et al. · Advances in Gerontology (Uspekhi Gerontologii) · 18-month-old rats under acute hypobaric hypoxia and moderate hypothermia

    Cortexin had a stronger effect than Pinealon on free-radical processes and brain caspase-3 activity. Both promoted accumulation of adrenergic mediators under hypoxia and of cortical serotonin under moderate hypothermia.

  7. 07Animal in vivo2014· Russian (English abstract)

    [Regulation of content of cytokines in blood serum and of caspase-3 activity in brains of old rats in model of sharp hypoxic hypoxia with Cortexin and Pinealon]

    Mendzheritskii AM, Karantysh GV, Ryzhak GA, Dem'ianenko SV · Advances in Gerontology (Uspekhi Gerontologii) · old rats, acute hypoxic hypoxia model; brain caspase-3 activity, serum IL-6 and TNF

    Under brain hypoxia Pinealon was reported to shift neuroinflammatory markers toward reference values, whereas Cortexin reduced programmed cell death but left IL-6 elevated.

  8. 08Animal in vivo2012

    Pinealon protects the rat offspring from prenatal hyperhomocysteinemia

    Arutjunyan A, Kozina L, Stvolinskiy S, Bulygina Y, Mashkina A, Khavinson V · International Journal of Clinical and Experimental Medicine · rat offspring of dams with methionine-loading-induced hyperhomocysteinaemia during pregnancy; behavioural testing and cerebellar neuron assays

    Pinealon given to pregnant rats improved offspring spatial orientation and learning and reduced reactive oxygen species accumulation and necrotic cell counts in isolated cerebellar neurons.

  9. 09In vitro2024

    Short Peptides Protect Fibroblast-Derived Induced Neurons from Age-Related Changes

    Kraskovskaya N, Linkova N, et al. · International Journal of Molecular Sciences · induced cortical neurons transdifferentiated from dermal fibroblasts of elderly human donors; EDR, KED and AEDG peptides

    All three peptides promoted dendritic arborisation, increasing the number of primary processes and total dendrite length. EDR specifically reduced oxidative DNA damage, while none of the peptides affected mitochondrial or lysosomal activity or p16 levels.

  10. 10In vitro2023

    Feasibility of Transport of 26 Biologically Active Ultrashort Peptides via LAT and PEPT Family Transporters

    Khavinson VK, Linkova NS, Rudskoy AI, Petukhov MG · Biomolecules · molecular modelling and computational docking of 26 ultrashort peptides against LAT1, LAT2 and PEPT1 transporters, benchmarked against 8400 di- and tripeptides

    EDR was among the peptides showing the highest predicted binding to LAT1, LAT2 and PEPT1, exceeding known substrates and inhibitors. The work is computational and the predicted transport has not been experimentally confirmed for EDR.

  11. 11In vitro2019

    Role of Mono- and Divalent Ions in Peptide Glu-Asp-Arg-DNA Interaction

    Silanteva IA, Komolkin AV, Morozova EA, Vorontsov-Velyaminov PN, Kasyanenko NA · The Journal of Physical Chemistry B · spectroscopy, NMR, viscosimetry and molecular dynamics of EDR-DNA binding

    EDR partly penetrated the major groove of DNA and contacted guanine N7 and O6 atoms, with Mg2+ promoting the interaction by screening phosphate charge. This provides the most direct physical evidence for the proposed peptide-DNA mechanism.

  12. 12In vitro2014

    Short peptides stimulate serotonin expression in cells of brain cortex

    Khavinson VKh, Lin'kova NS, Tarnovskaya SI, Umnov RS, Elashkina EV, Durnova AO · Bulletin of Experimental Biology and Medicine · ageing brain cortex cell cultures plus molecular docking of peptide to the tryptophan hydroxylase gene

    Glu-Asp-Arg and Lys-Glu-Asp increased serotonin expression in ageing cortical cell cultures. Docking identified a CCTGCC sequence in the 5-tryptophan hydroxylase gene complementary to these peptides.

  13. 13In vitro2013

    Interaction of short peptides with FITC-labeled wheat histones and their complexes with deoxyribooligonucleotides

    Fedoreyeva LI, et al. · Biochemistry (Moscow) · fluorescence binding assays with FITC-labelled histones and deoxyribooligonucleotide complexes

    Short peptides including EDR bound histone proteins and histone-oligonucleotide complexes, supporting the proposed chromatin-level interaction.

  14. 14In vitro2012

    Effect of bioregulatory tripeptides on the culture of skin cells from young and old rats

    Voicekhovskaya MA, et al. · Bulletin of Experimental Biology and Medicine · skin cell cultures from young and old rats treated with bioregulatory tripeptides

    Bioregulatory tripeptides altered proliferative behaviour of skin cell cultures with age-dependent differences, part of the group's broader tissue-specificity claim for short peptides.

  15. 15In vitro2011

    Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA

    Fedoreyeva LI, et al. · Biochemistry (Moscow) · HeLa cells with fluorescence-labelled short peptides; DNA and oligonucleotide binding assays

    Fluorescently labelled short peptides entered the nucleus of HeLa cells and showed sequence-specific interaction with deoxyribooligonucleotides and DNA in vitro.

  16. 16In vitro2011

    Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes

    Khavinson V, Ribakova Y, Kulebiakin K, Vladychenskaya E, Kozina L, Arutjunyan A, Boldyrev A · Rejuvenation Research · cerebellar granule cells, neutrophils and PC12 cells under receptor-dependent and receptor-independent oxidative stress

    Pinealon dose-dependently restricted reactive oxygen species accumulation and reduced necrotic cell death, with delayed ERK1/2 activation and cell cycle modification. The authors concluded that cell-cycle effects at higher concentrations imply direct interaction with the genome beyond antioxidant activity.

  17. 17In vitro2011

    Effect of short peptides on expression of signaling molecules in organotypic pineal cell culture

    Khavinson VKh, et al. · Bulletin of Experimental Biology and Medicine · organotypic pineal cell culture

    Short peptides including EDR altered expression of signalling molecules in organotypic pineal cell culture, the model from which the Pinealon trade name derives.

  18. 18Revisión2024· Russian (English abstract)

    [Prospects for use of short peptides in pharmacotherapeutic correction of Alzheimer's disease.]

    Ilina AR, Popovich IG, Ryzhak GA, Khavinson VK · Advances in Gerontology (Uspekhi Gerontologii) · narrative review of short peptides in Alzheimer's disease therapy

    The review described Glu-Asp-Arg among a set of short peptides (with Leu-Ile, Glu-Trp, Lys-Glu, Gly-Pro, Lys-Glu-Asp and Semax) proposed as multitarget agents for Alzheimer's disease, arguing for a combination rather than single-target strategy.

  19. 19Revisión2022

    Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer's Disease

    Ilina A, Khavinson V, Linkova N, Petukhov M · International Journal of Molecular Sciences · narrative review of epigenetic mechanisms

    The authors set out the hypothesis that ultrashort peptides regulate gene expression through interaction with histone proteins, cis- and trans-regulatory DNA elements and DNA/RNA-binding proteins. The mechanism is presented explicitly as a hypothesis.

  20. 20Revisión2020

    EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease

    Khavinson V, Linkova N, Kozhevnikova E, Trofimova S · Molecules · mechanistic review of EDR peptide in Alzheimer's disease pathogenesis

    The review proposed that EDR enters cells and binds histone proteins or nucleic acids, altering MAPK/ERK signalling and synthesis of caspase-3, p53, SOD2, GPX1, PPARA and PPARG. The authors described improved memory in elderly patients as a prior finding without presenting new controlled trial data.

  21. 21Revisión2013· Russian (English abstract)

    [Neuroprotective effects of peptides bioregulators in people of various age]

    Umnov RS, et al. · Advances in Gerontology (Uspekhi Gerontologii) · review of peptide bioregulators including EDR in human populations of different ages

    The review summarised claims of neuroprotective effects of peptide bioregulators across age groups. It is a narrative synthesis from the originating research group rather than an independent evaluation.

Limitaciones

Lo que esta evidencia no establece.

There is no randomised, placebo-controlled trial of Pinealon or EDR alone in humans, no pharmacokinetic data, and no demonstration that orally or parenterally administered EDR reaches brain tissue intact at physiologically relevant concentrations. Essentially the entire body of evidence originates from one research group in St Petersburg, and the central epigenetic mechanism rests on molecular docking and in vitro binding rather than in vivo target engagement. Independent replication outside this group is effectively absent.

Preguntas comunes sobre la investigación.

What is Pinealon?

Pinealon is the synthetic tripeptide Glu-Asp-Arg, abbreviated EDR. It belongs to the family of short peptide bioregulators developed by the Khavinson group in St Petersburg, which also includes Epithalon.

How strong is the evidence base?

Thin. The published record is small, largely produced by one research school, and short on independent replication. In vitro nuclear-penetration and free-radical findings are the most concrete results; the human reports are observational rather than randomised. Treat any account of Pinealon's activity as provisional.

What is the proposed mechanism?

The bioregulator literature proposes an epigenetic mode of action: short peptides entering the cell nucleus and interacting with specific double-stranded DNA sequences to influence transcription, rather than binding a cell-surface receptor. Supporting evidence exists in cell-free and cell-culture systems; it has not been demonstrated to operate this way in intact human tissue.

Disponible en nuestro catálogo

Solo para fines de investigación. No apto para consumo humano, diagnóstico, tratamiento o prevención de ninguna condición. Nada en esta página constituye consejo médico, y ningún estudio resumido aquí debe leerse como una recomendación.